Arylium Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Arylium General Information
Description
Developer of a biotechnology platform designed for the discovery of novel pharmaceuticals from turmeric-based compounds. The company's technology utilizes turmerone extraction and molecular target identification to facilitate drug development, enabling healthcare providers to manage epilepsy, neurological disorders, and inflammatory diseases through a specialized framework of clinical-stage medicines and dietary supplements.
Contact Information
Website
www.arylium.comCorporate Office
- Bloomington, IN
- United States
Corporate Office
- Bloomington, IN
- United States
Arylium Timeline
Arylium Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 22-Jul-2026 | Completed | Startup | |||
| 1. Seed Round | 06-Apr-2026 | Completed | Startup |
Arylium Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AgriNovus Indiana | Accelerator/Incubator | |||
| Elevate Ventures | Venture Capital | Minority |
Arylium FAQs
-
Where is Arylium headquartered?
Arylium is headquartered in Bloomington, IN.
-
What industry is Arylium in?
Arylium’s primary industry is Drug Discovery.
-
Is Arylium a private or public company?
Arylium is a Private company.
-
What is Arylium’s current revenue?
The current revenue for Arylium is .
-
How much funding has Arylium raised over time?
Arylium has raised $100K.
-
Who are Arylium’s investors?
AgriNovus Indiana and Elevate Ventures have invested in Arylium.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process